Scientist II (Cell Therapy / Genome Engineering) at Dawar Consulting, Inc. | South San Francisco | Rezi

Scientist II (Cell Therapy / Genome Engineering) at Dawar Consulting, Inc.

Scientist II (Cell Therapy / Genome Engineering)

Dawar Consulting, Inc. · South San Francisco

1 months ago

Scientist II (Cell Therapy / Genome Engineering)

Dawar Consulting, Inc. · South San Francisco

a month ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

This role supports genome engineering and synthetic biology initiatives, contributing to cell therapy development and disease-modeling programs. The successful candidate will support the Advanced Cell Engineering Hub in engineering and profiling cells for cell therapy development and disease modeling.

Responsibilities

  • Engineer mammalian cells (cancer cell lines, iPSCs, primary cells) using lentiviral/piggyBac systems and CRISPR gene editing
  • Optimize transfection and gene-editing workflows
  • Troubleshoot and refine cell engineering protocols
  • Characterize engineered cells using molecular and genomic assays
  • Maintain, monitor, and quality-check cell lines in culture

Requirements

  • BS/MS + 5 years industry experience or PhD in Molecular Biology, Cell Biology, Genetics, or related field
  • Strong hands-on mammalian cell culture experience

Skills

  • DNA/RNA/protein extraction
  • molecular cloning
  • PCR/RT-PCR/ddPCR
  • FACS
  • CRISPR editing
  • siRNA/shRNA
  • SDS-PAGE
  • immunoblotting
  • cell-based assays
  • NGS
  • viral vector work
  • Benchling
  • SnapGene
  • FlowJo
  • GraphPad Prism

Location

  • South San Francisco, CA

Work Type

  • Long-Term Contract

Experience Level

  • 5 years industry experience (with BS/MS)
  • PhD

Education Level

  • BS/MS
  • PhD

Salary/Compensations

  • $60-$65/hr on W2

Benefits

  • Medical
  • Dental
  • Vision
  • Paid Sick Leave
  • 401K

About the Company

  • Our client is a world leader in biotechnology and life sciences.